BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9820844)

  • 1. The A enhancer of polyomavirus: protein-protein interactions for the differential early and late promoter function under nonreplicating conditions.
    Shivakumar CV; Das GC
    Intervirology; 1998; 41(2-3):103-9. PubMed ID: 9820844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEA1 and PEA3 enhancer elements are primary components of the polyomavirus late transcription initiator element.
    Yoo W; Martin ME; Folk WR
    J Virol; 1991 Oct; 65(10):5391-400. PubMed ID: 1654447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of transcription factors binding to the duplicated PEA1 and PEA3 sites that are required for polyomavirus mutant expression in PCC4 embryonic carcinoma cells.
    Nothias JY; Weinmann R; Blangy D; Melin F
    J Virol; 1993 Jun; 67(6):3036-47. PubMed ID: 8388487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins.
    Martin ME; Piette J; Yaniv M; Tang WJ; Folk WR
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):5839-43. PubMed ID: 2842750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and mutational analysis of the polyomavirus core promoter: involvement of nuclear factor-1 in early promoter function.
    Shivakumar CV; Das GC
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1281-90. PubMed ID: 8207394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal subenhancer requirements for high-level polyomavirus DNA replication: a cell-specific synergy of PEA3 and PEA1 sites.
    Rochford R; Davis CT; Yoshimoto KK; Villarreal LP
    Mol Cell Biol; 1990 Sep; 10(9):4996-5001. PubMed ID: 2167444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two novel YY1 binding sites in the polyomavirus late promoter.
    Martelli F; Iacobini C; Caruso M; Felsani A
    J Virol; 1996 Mar; 70(3):1433-8. PubMed ID: 8627660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer-mediated role for polyomavirus middle T/small T in DNA replication.
    Chen MC; Redenius D; Osati-Ashtiani F; Fluck MM
    J Virol; 1995 Jan; 69(1):326-33. PubMed ID: 7983726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of EF-C/RFX-1 with the inverted repeat of viral enhancer regions is required for transactivation.
    David E; Garcia AD; Hearing P
    J Biol Chem; 1995 Apr; 270(14):8353-60. PubMed ID: 7713944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HeLa cell nuclear factors that bind to and activate the early promoter of human polyomavirus BK in vitro.
    Chakraborty T; Das GC
    Mol Cell Biol; 1989 Sep; 9(9):3821-8. PubMed ID: 2550803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tumor promoting phorbol ester, TPA, enhances polyomavirus DNA replication by activating the function of the viral enhancer.
    Murakami Y; Asano M; Satake M; Ito Y
    Oncogene; 1990 Jan; 5(1):5-13. PubMed ID: 2157181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The late promoter of the human papovavirus BK is contained within the early promoter enhancer region.
    Cassill JA; Subramani S
    Virology; 1988 Sep; 166(1):175-85. PubMed ID: 2842943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteins of the nuclear factor-1 family act as an activator of the late promoter in human polyomavirus BK in vitro.
    Chakraborty T; Das GC
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1935-42. PubMed ID: 1651986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polyomavirus enhancer-binding protein, PEBP5, responsive to 12-O-tetradecanoylphorbol-13-acetate but distinct from AP-1.
    Asano M; Murakami Y; Furukawa K; Yamaguchi-Iwai Y; Satake M; Ito Y
    J Virol; 1990 Dec; 64(12):5927-38. PubMed ID: 2173774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer.
    Kamachi Y; Ogawa E; Asano M; Ishida S; Murakami Y; Satake M; Ito Y; Shigesada K
    J Virol; 1990 Oct; 64(10):4808-19. PubMed ID: 2168969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imperfect Symmetry of Sp1 and Core Promoter Sequences Regulates Early and Late Virus Gene Expression of the Bidirectional BK Polyomavirus Noncoding Control Region.
    Bethge T; Ajuh E; Hirsch HH
    J Virol; 2016 Nov; 90(22):10083-10101. PubMed ID: 27581987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activity in 3T3, F9, and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer.
    Trotot P; Mechali F; Blangy D; Lacasa M
    Virology; 1994 Aug; 202(2):724-34. PubMed ID: 8030236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of regulation of polyomavirus promoters by a luciferase reporter system.
    Spanielová H
    Acta Virol; 2002; 46(4):219-27. PubMed ID: 12693858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of human polyomavirus BK with the tumor-suppressor protein p53.
    Shivakumar CV; Das GC
    Oncogene; 1996 Jul; 13(2):323-32. PubMed ID: 8710371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer effect of bovine papillomavirus E2 protein in replication of polyomavirus DNA.
    Nilsson M; Forsberg M; You ZY; Westin G; Magnusson G
    Nucleic Acids Res; 1991 Dec; 19(25):7061-5. PubMed ID: 1662803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.